A robust prognostic signature for hormone-positive node-negative breast cancer

被引：0
|
作者：
Obi L Griffith
François Pepin
Oana M Enache
Laura M Heiser
Eric A Collisson
Paul T Spellman
Joe W Gray
机构：
[1] Lawrence Berkeley National Laboratory,Department of Cancer and DNA Damage Responses, Life Sciences Division
[2] The Genome Institute,Department of Medicine, Division of Oncology
[3] Washington University,Department of Biomedical Engineering
[4] Sequenta Inc.,Division of Hematology/Oncology
[5] Center for Spatial Systems Biomedicine,Department of Molecular and Medical Genetics
[6] Knight Cancer Institute,undefined
[7] Oregon Health and Science University,undefined
[8] University of California San Francisco,undefined
[9] Oregon Health and Science University,undefined
来源：
Genome Medicine | / 5卷
关键词：
Breast Cancer; Lawrence Berkeley National Laboratory; Relapse Event; Affymetrix U133A; Independent Test Dataset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
    Foekens, JA
    Atkins, D
    Zhang, Y
    Sweep, FCGJ
    Harbeck, N
    Paradiso, A
    Cufer, T
    Sieuwerts, AM
    Talantov, D
    Span, PN
    Tjan-Heijnen, VCG
    Zito, AF
    Specht, K
    Hoefler, H
    Golouh, R
    Schittulli, F
    Schmitt, M
    Beex, LVAM
    Klijn, IGM
    Wang, YX
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) : 1665 - 1671
  • [42] Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?
    Modlich, Olga
    Bojar, Hans
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (04): : 216 - 217
  • [43] Effect of E-cadherin expression in hormone-positive and hormone negative breast cancer patients
    Ahmed, S. S.
    Iqbal, J.
    Thike, A. A.
    Tan, P. H.
    HISTOPATHOLOGY, 2012, 61 : 11 - 11
  • [44] Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?
    Olga Modlich
    Hans Bojar
    Nature Clinical Practice Oncology, 2007, 4 : 216 - 217
  • [45] NODE-NEGATIVE BREAST-CANCER
    COOMBES, RC
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 958 - 958
  • [46] Validation of 70-gene prognosis signature in node-negative breast cancer
    Bueno-de-Mesquita, J. M.
    Linn, S. C.
    Keijzer, R.
    Wesseling, J.
    Nuyten, D. S. A.
    van Krimpen, C.
    Meijers, C.
    de Graaf, P. W.
    Bos, M. M. E. M.
    Hart, A. A. M.
    Rutgers, E. J. T.
    Peterse, J. L.
    Halfwerk, H.
    de Groot, R.
    Pronk, A.
    Floore, A. N.
    Glas, A. M.
    van't Veer, L. J.
    van de Vijver, M. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 483 - 495
  • [47] Validation of 70-gene prognosis signature in node-negative breast cancer
    J. M. Bueno-de-Mesquita
    S. C. Linn
    R. Keijzer
    J. Wesseling
    D. S. A. Nuyten
    C. van Krimpen
    C. Meijers
    P. W. de Graaf
    M. M. E. M. Bos
    A. A. M. Hart
    E. J. T. Rutgers
    J. L. Peterse
    H. Halfwerk
    R. de Groot
    A. Pronk
    A. N. Floore
    A. M. Glas
    L. J. van’t Veer
    M. J. van de Vijver
    Breast Cancer Research and Treatment, 2009, 117 : 483 - 495
  • [48] Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer
    Brittany L. Murphy
    Tanya L. Hoskin
    Courtney Day N. (Heins)
    Elizabeth B. Habermann
    Judy C. Boughey
    Annals of Surgical Oncology, 2017, 24 : 2518 - 2525
  • [49] Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer
    Murphy, Brittany L.
    Hoskin, Tanya L.
    , Courtney Day N.
    Habermann, Elizabeth B.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2518 - 2525
  • [50] Prognostic factors in node-negative gastric cancer
    Bruno, L
    Montinaro, F
    BRITISH JOURNAL OF SURGERY, 1998, 85 : 50 - 51
12345